Title: Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups.
Journal: Bioorganic & medicinal chemistry 20110815
130205-11-7
159506-17-9
2612-02-4
2785-98-0
28917-43-3
2905-82-0
1616526-85-2 | 5-Fluoro-1-methyl-3-nitropyridin-2(1h)-one | AA001VOX | MFCD28099326
1653-64-1 | 1,3-Benzodioxole-5-ethanamine, hydrochloride (1:1) | AA001VZL | MFCD00035193
16574-43-9 | Bromopyrogallol red | AA001W9G | MFCD00148865
16630-60-7 | 3-(Methylsulfanyl)propyl butanoate | AA001WJG | MFCD28098304
1666-17-7 | Benzaldehyde tosylhydrazone | AA001WRU | MFCD00009644
1671-76-7 | 1-Pentanone, 1-(4-methoxyphenyl)- | AA001X1X | MFCD00027236
16741-27-8 | Acetobromofucose | AA001XB1 | MFCD04039371
167871-30-9 | Tetradecyl isobutyrate | AA001XLO | MFCD30470137
16832-21-6 | 1,2-O-Cyclohexylidene-alpha-d-glucofuranose | AA001XXW | MFCD00142481
16874-33-2 | 2-Tetrahydrofuroic acid | AA001Y70 | MFCD00022473